Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

2.

Strength Analyses of Screws for Femoral Neck Fractures.

Frydrýšek K, Šír M, Pleva L.

J Med Biol Eng. 2018;38(5):816-834. doi: 10.1007/s40846-018-0378-x. Epub 2018 Apr 20.

3.

Long-term outcomes after treatment of bare-metal stent restenosis with paclitaxel-coated balloon catheters or everolimus-eluting stents: 3-year follow-up of the TIS clinical study.

Pleva L, Kukla P, Zapletalova J, Hlinomaz O.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):E416-E424. doi: 10.1002/ccd.27688. Epub 2018 Jul 18.

PMID:
30019843
4.

Treatment of coronary in-stent restenosis: a systematic review.

Pleva L, Kukla P, Hlinomaz O.

J Geriatr Cardiol. 2018 Feb;15(2):173-184. doi: 10.11909/j.issn.1671-5411.2018.02.007. Review.

5.

GENERAL HEALTH STATUS AMONG FIREFIGHTERS AND RESCUE OPERATIONS WORKERS.

Ibrayeva A, Turdalieva B, Aimbetova G, Pleva L.

Georgian Med News. 2017 Sep;(270):130-135.

PMID:
28972498
6.

Analysis of Locking Self-Taping Bone Screws for Angularly Stable Plates.

Čada R, Frydrýšek K, Sejda F, Demel J, Pleva L.

J Med Biol Eng. 2017;37(4):612-625. doi: 10.1007/s40846-017-0279-4. Epub 2017 Jun 21.

7.

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis.

Pleva L, Kukla P, Zapletalova J, Hlinomaz O.

BMC Cardiovasc Disord. 2017 Jun 26;17(1):168. doi: 10.1186/s12872-017-0602-6.

8.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

9.

Response by Pleva et al to Letter Regarding Article, "Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study".

Pleva L, Kukla P, Kusnierova P, Zapletalova J, Hlinomaz O.

Circ Cardiovasc Interv. 2016 Sep;9(9). pii: e004304. doi: 10.1161/CIRCINTERVENTIONS.116.004304. No abstract available.

PMID:
27613770
10.

Comparison of the Efficacy of Paclitaxel-Eluting Balloon Catheters and Everolimus-Eluting Stents in the Treatment of Coronary In-Stent Restenosis: The Treatment of In-Stent Restenosis Study.

Pleva L, Kukla P, Kusnierova P, Zapletalova J, Hlinomaz O.

Circ Cardiovasc Interv. 2016 Apr;9(4):e003316. doi: 10.1161/CIRCINTERVENTIONS.115.003316.

PMID:
27069104
11.

The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.

Pleva L, Kovarova P, Faldynova L, Plevova P, Hilscherova S, Zapletalova J, Kusnierova P, Kukla P.

BMC Cardiovasc Disord. 2015 Oct 24;15:135. doi: 10.1186/s12872-015-0128-8.

12.

Increased levels of MMP-3, MMP-9 and MPO represent predictors of in-stent restenosis, while increased levels of ADMA, LCAT, ApoE and ApoD predict bare metal stent patency.

Pleva L, Kusnierova P, Plevova P, Zapletalova J, Karpisek M, Faldynova L, Kovarova P, Kukla P.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Dec;159(4):586-94. doi: 10.5507/bp.2015.037. Epub 2015 Sep 3.

13.

Reference intervals of plasma matrix metalloproteinases 2, 3, and 9 and serum asymmetric dimethylarginine levels.

Kusnierova P, Vsiansky F, Pleva L, Plevova P, Safarcik K, Svagera Z.

Scand J Clin Lab Invest. 2015 Oct;75(6):508-13. doi: 10.3109/00365513.2015.1057760. Epub 2015 Jul 7.

PMID:
26151887
14.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

15.

Tissue ischemia microdialysis assessments following severe traumatic haemorrhagic shock: lactate/pyruvate ratio as a new resuscitation end point?

Burša F, Pleva L, Máca J, Sklienka P, Ševčík P.

BMC Anesthesiol. 2014 Dec 15;14:118. doi: 10.1186/1471-2253-14-118. eCollection 2014.

16.

[Multiple trauma - treatment of skeletal injuries with damage control orthopaedics].

Sír M, Pleva L, Procházka V.

Rozhl Chir. 2014 May;93(5):287-91. Czech.

PMID:
24891247
18.

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

Nicholls SJ, Kastelein JJ, Schwartz GG, Bash D, Rosenson RS, Cavender MA, Brennan DM, Koenig W, Jukema JW, Nambi V, Wright RS, Menon V, Lincoff AM, Nissen SE; VISTA-16 Investigators.

JAMA. 2014 Jan 15;311(3):252-62. doi: 10.1001/jama.2013.282836.

PMID:
24247616
19.

[Incidence of proximal femur fractures in relation to seasons of the year and weather].

Burget F, Pleva L, Kudrna K, Kudrnová Z.

Acta Chir Orthop Traumatol Cech. 2012;79(2):140-3. Czech.

PMID:
22538105
20.

[Right ventricular perforation by a rib fragment following blunt thoracic trauma].

Pometlová J, Pleva L, Sír M, Gloger J, Chmelová J.

Rozhl Chir. 2011 Nov;90(11):656-60. Czech.

PMID:
22442879

Supplemental Content

Loading ...
Support Center